Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives
Haemophilia · 2025
DOI: 10.1111/hae.70178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Haemophilia, 2025. Verfasst von Sébastien Lobet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Haemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Hauptthemen laut MEDLINE: Hemophilia A, Joint Diseases, Elbow Joint. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Introduction
Haemophilic elbow arthropathy (HEA) causes pain, limits mobility, and impairs upper limb function, often unrecognised until irreversible damage has occurred.
Aims
This narrative review sought to provide an updated overview of the current state of HEA knowledge, treatment approaches, and future perspectives.
Methods
We searched the PubMed/Medline, Embase and Scopus (through April 2025) databases for English articles using a combination of controlled vocabulary and free‐text keywords related to haemophilia, elbow arthropathy, range of motion, physiotherapy, surgical interventions, and joint assessment. The review was organised around six key themes: normal function of the elbow, progressive loss of its mobility and functionality, monitoring, role of physiotherapy and exercise, invasive solutions, and future perspectives. A total of 60 articles were retrieved, 45 of which were examined in depth.
Results
HEA significantly affects the quality of life of people with haemophilia (PwH). Its insidious onset, coupled with the body's ability to compensate, frequently obscures the severity of mobility loss, leading to delayed interventions and irreversible joint damage. Early detection, precise monitoring, and targeted physiotherapy are crucial to slowing down disease progression and optimising functional outcomes. Surgical interventions are considered only in advanced‐stage HEA, and are typically reserved for cases where conservative treatments have proven insufficient. Technological and telemedicine advances provide novel avenues to optimise care and promote patient self‐management.
Conclusions
HEA is a progressive, often overlooked condition that reduces quality of life in PwH, highlighting the need for early detection, monitoring, and targeted physiotherapy to prevent irreversible joint damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Service D'ergothérapie Et De Kinésithérapie, Cliniques Universitaires Saint-Luc, Université Catholique De Louvain (UCLouvain), Brussels, Belgium.
- Neuromusculoskeletal Lab (NMSK), Secteur Des Sciences de La Santé, Institut De Recherche Expérimentale Et Clinique, Université Catholique De Louvain (UCLouvain), Brussels, Belgium.
- Department of Orthopaedic Surgery, Cliniques Universitaires Saint-Luc, Université Catholique De Louvain (UCLouvain), Brussels, Belgium.
ORCID-Profile: Sébastien Lobet, Olivier Barbier, Catherine Lambert, Dorian Lippens, Cedric Hermans
Zitieren
APA
Lobet, S., Barbier, O., Lambert, C., Lippens, D., Hermans, C., & Libouton, X. (2025). Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives. Haemophilia. https://doi.org/10.1111/hae.70178
Vancouver
Lobet S, Barbier O, Lambert C, Lippens D, Hermans C, Libouton X. Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives. Haemophilia. 2025. doi:10.1111/hae.70178
BibTeX
@article{Lobet2025,
author = {Lobet, Sébastien and Barbier, Olivier and Lambert, Catherine and Lippens, Dorian and Hermans, Cedric and Libouton, Xavier},
title = {Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.70178}
}
EUVIMED